Not finding it? Sign in to also search OpenAlex live.
-
Breast Cancer Index Predicts Extended Endocrine Benefit to Individualize Selection of Patients with HR+ Early-stage Breast Cancer for 10 Years of Endocrine Therapy2020 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access cited by 1 patent
Iris Noordhoek, Kai Treuner, Hein Putter, Yi Zhang, Jenna Wong, Elma Meershoek‐Klein Kranenbarg, +4 more
133citations -
Selection of Patients With Early-Stage Breast Cancer for Extended Endocrine Therapy2024 JAMA Network Open article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access cited by 1 patent
Laura van ‘t Veer, Elma Meershoek‐Klein Kranenbarg, Marjolijn Duijm‐de Carpentier, Cornelis J. H. van de Velde, Miranda Kleijn, Christa Dreezen, +3 more
12citations -
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer2023 New England Journal of Medicine article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, Fedro Alessandro Peccatori, Hatem A. Azim, Marco Angelo Colleoni, +32 more
229citations -
Neoadjuvant endocrine therapy often leads to breast and axilla‐conserving surgery in stages II and III hormone receptor‐positive breast cancer patients: A registry study2025 International Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Layla Andour, Judith R. Kroep, Hein Putter, Rob A.�E.�M. Tollenaar, Wilma E. Mesker, Marieke Evelien Straver
4citations -
Side-effects in women treated with adjuvant endocrine therapy for breast cancer2025 The Breast article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Roxanne Gal, Anne Maria May, Marilot C. T. Batenburg, Femke van der Leij, Rhodé M. Bijlsma, Helena Marieke Verkooijen, +5 more
17citations -
The Predictive Value of the Tumor‐Stroma Ratio for Neoadjuvant Endocrine Therapy in Hormone Receptor‐Positive Breast Cancer2026 International Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Layla Andour, Sophie C. Hagenaars, Anne Florine de Groot, Elly MM Krol-Warmerdam, Judith R. Kroep, Hans Marten Hazelbag, +3 more
1citations -
Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial2023 EClinicalMedicine article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Vivianne C. G. Tjan‐Heijnen, Senna W. M. Lammers, Sandra M. E. Geurts, Ingeborg J. H. Vriens, Astrid C P Swinkels, Carolien H. Smorenburg, +8 more
16citations -
Safety and efficacy of nintedanib as second-line therapy for patients with differentiated or medullary thyroid cancer progressing after first-line therapy. A randomized phase II study of the EORTC Endocrine Task Force (protocol 1209-EnTF)
Sophie Leboulleux, Ellen Kapiteijn, Saskia Litière, Patrick Schöffski, Yann Godbert, Patrice Rodien, +14 more
8citations -
Daily Oral Ibandronate With Adjuvant Endocrine Therapy in Postmenopausal Women With Estrogen Receptor–Positive Breast Cancer (BOOG 2006-04): Randomized Phase III TEAM-IIB Trial
Sonja B. Vliek, Iris Noordhoek, Elma Meershoek‐Klein Kranenbarg, Annelot G.J. van Rossum, Vincent Olaf Dezentjé, Agnes Jager, +12 more
21citations -
Association between endocrine therapy and cognitive decline in older women with early breast cancer: Findings from the prospective CLIMB study2023 European Journal of Cancer article Medicine Cancer-related cognitive impairment studies Open access
Joosje C. Baltussen, Marloes G.M. Derks, Annelieke A. Lemij, Nienke A. de Glas, Marta F. Fiocco, E. Linthorst-Niers, +10 more
9citations -
The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy2023 Breast Cancer Research and Treatment article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Mariëtte E. C. Waaijer, Annelieke A. Lemij, Anna Z. de Boer, E. Bastiaannet, Frederiek van den Bos, M.G.M. Derks, +4 more
3citations -
Biomarker-based risk stratification for predicting late recurrence and benefit of extended endocrine therapy: A secondary analysis of the IDEAL trial2026 The Breast article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Tejal Deepak Durgekar, Shyamili Goutham, Xi Zhang, Elma Meershoek‐Klein Kranenbarg, Badada Ananthamurthy Savitha, Shrivastava Pn, +8 more
1citations -
Pathway activity profiling can predict neoadjuvant endocrine therapy response in HR+ HER2- postmenopausal early stage breast cancer2026 Breast Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Nadia de Gruil, A. F. de Groot, Yvonne J.W. Wesseling-Rozendaal, D. Keizer, C.S. Koekenbier, Saskia Vermeer, +13 more
0citations -
94MO The prognostic and predictive effect of BMI in postmenopausal HR+ breast cancer patients receiving (extended) endocrine therapy: DATA trial analysis
S.W.M. Lammers, Sandra M. E. Geurts, Irene E.G. van Hellemond, Astrid C P Swinkels, Carolien H. Smorenburg, Maurice van der Sangen, +10 more
0citations -
133O Extended adjuvant aromatase inhibition after sequential endocrine therapy: Final results of the phase III DATA trial2022 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
V.C.G. Tjan-Heijnen, S.W.M. Lammers, Sandra M. E. Geurts, Ingeborg J. H. Vriens, Astrid C P Swinkels, Carolien H. Smorenburg, +8 more
5citations -
European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency2024 The Journal of Clinical Endocrinology & Metabolism article Medicine Adrenal Hormones and Disorders Open access
Felix Beuschlein, Tobias Else, Irina Bancos, Stefanie Hahner, Oksana Hamidi, Leonie Theresia van Hulsteijn, +6 more
143citations -
60MO Ovarian function in young patients (pts) treated with postneoadjuvant palbociclib (PAL) and endocrine therapy (ET) for hormone receptor (HR)-positive, HER2-negative early breast cancer (BC): Explorative analysis in Penelope-B
Jenny Furlanetto, Federick Marme, C. Thode, Valentina Nekljudova, Y. Liu, M. Martín Jiménez, +14 more
11citations